Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Columbia Research Enhanced Value ETF (REVS) belongs to the US Large Cap Value segment. Invesco Comstock Contrarian Equity ETF (CSTK) is part of the Uncategorized Equities segment. REVS's top 3 sector exposures are Financials, Health Care and Industrials. In contrast, CSTK's top sector exposures are Financials, Health Care and Information Technology. REVS is less expensive with a Total Expense Ratio (TER) of 0.19%, versus 0.35% for CSTK. REVS is up 1.84% year-to-date (YTD) with +$74M in YTD flows. CSTK performs worse with 0.17% YTD performance, and +$6M in YTD flows. Run a side-by-side ETF comparison of REVS and CSTK below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | REVS CSTK | -3.72%-5.21% | +0.55%+0.02% | +1.84%+0.17% | +19.40%n/a | +60.84%n/a | +71.76%n/a |
| Flows | REVS CSTK | +$13M+$6M | +$79M+$1M | +$74M+$6M | +$138M- | +$173M- | +$193M- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | REVS CSTK | +10.96%+11.53% | +15.96%n/a | +13.35%n/a | +15.12%n/a |
| Max drawdown | REVS CSTK | -4.35%-6.65% | -12.32%n/a | -16.16%n/a | -17.78%n/a |
| Max drawdown duration | REVS CSTK | 30d29d | 46dn/a | 211dn/a | 448dn/a |
REVS | CSTK | |
Last sale 3/12/2026 at 1:30 PM | $28.45 | $29.22 |
| Previous close 03/12/2026 | $28.72 | $29.14 |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
REVS | CSTK | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
REVS | CSTK | |
|---|---|---|
| Last price | $28.45 | $29.22 |
| 1D performance | -0.93% | +0.28% |
| AuM | $213.52 M | $115.68 M |
| E/R | 0.19% | 0.35% |
REVS | CSTK | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Columbia Threadneedle Investments | Invesco |
| Benchmark | Beta Advantage Research Enhanced U.S. Value Index | - |
| N° of holdings | 281 | 52 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 25, 2019 | May 7, 2025 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.